Bosh sahifaBNTC • NASDAQ
add
Benitec Biopharma Inc
12,74 $
Seans yopilganidan keyin:(0,00%)0,00
12,74 $
Yopilgan:2-iyl, 16:01:23 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
12,11 $
Kunlik diapazon
12,08 $ - 12,95 $
Yillik diapazon
7,05 $ - 17,15 $
Bozor kapitalizatsiyasi
334,43 mln USD
Oʻrtacha hajm
161,50 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 10,19 mln | 145,85% |
Sof foyda | -9,35 mln | -118,60% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | — | — |
EBITDA | -10,18 mln | -147,21% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 103,58 mln | 632,40% |
Jami aktivlari | 105,21 mln | 601,44% |
Jami passivlari | 7,64 mln | 118,32% |
Umumiy kapital | 97,57 mln | — |
Tarqatilgan aksiyalar | 25,60 mln | — |
Narxi/balansdagi bahosi | 3,17 | — |
Aktivlardan daromad | -27,64% | — |
Kapitaldan daromad | -29,17% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -9,35 mln | -118,60% |
Operatsiyalardan naqd pul | -3,09 mln | 49,97% |
Sarmoyadan naqd pul | -6,00 ming | 96,65% |
Moliyadan naqd pul | 28,41 mln | — |
Naqd pulning sof oʻzgarishi | 25,30 mln | 505,99% |
Boʻsh pul | 60,50 ming | 101,31% |
Haqida
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology.
The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research. Wikipedia
Tashkil etilgan
1997
Sayt
Xodimlar soni
16
